CY1114577T1 - Αποτροπη και θεραπεια υπο-κλινικης pcvd - Google Patents
Αποτροπη και θεραπεια υπο-κλινικης pcvdInfo
- Publication number
- CY1114577T1 CY1114577T1 CY20131100982T CY131100982T CY1114577T1 CY 1114577 T1 CY1114577 T1 CY 1114577T1 CY 20131100982 T CY20131100982 T CY 20131100982T CY 131100982 T CY131100982 T CY 131100982T CY 1114577 T1 CY1114577 T1 CY 1114577T1
- Authority
- CY
- Cyprus
- Prior art keywords
- subclinical
- pcvd
- obstruction
- therapy
- pcv2
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20070102250 EP1958644A1 (en) | 2007-02-13 | 2007-02-13 | Prevention and treatment of sub-clinical pcvd |
| EP08708877.9A EP2114447B1 (en) | 2007-02-13 | 2008-02-11 | Prevention and treatment of sub-clinical pcvd |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114577T1 true CY1114577T1 (el) | 2016-10-05 |
Family
ID=38191300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100982T CY1114577T1 (el) | 2007-02-13 | 2013-11-06 | Αποτροπη και θεραπεια υπο-κλινικης pcvd |
Country Status (23)
| Country | Link |
|---|---|
| US (5) | US7943298B2 (enExample) |
| EP (3) | EP1958644A1 (enExample) |
| JP (1) | JP5562041B2 (enExample) |
| KR (1) | KR101521465B1 (enExample) |
| CN (1) | CN101610786B (enExample) |
| AR (1) | AR065319A1 (enExample) |
| AU (1) | AU2008214639B2 (enExample) |
| BR (1) | BRPI0807493A2 (enExample) |
| CA (1) | CA2676568C (enExample) |
| CL (1) | CL2008000445A1 (enExample) |
| CY (1) | CY1114577T1 (enExample) |
| DK (2) | DK2481421T3 (enExample) |
| ES (2) | ES2434117T3 (enExample) |
| MX (1) | MX2009008577A (enExample) |
| MY (1) | MY152149A (enExample) |
| PL (1) | PL2114447T3 (enExample) |
| PT (1) | PT2114447E (enExample) |
| RU (1) | RU2520759C2 (enExample) |
| SI (1) | SI2114447T1 (enExample) |
| TW (1) | TWI438003B (enExample) |
| UA (1) | UA100507C2 (enExample) |
| WO (1) | WO2008098909A1 (enExample) |
| ZA (1) | ZA200904806B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| ES2553254T3 (es) | 2005-12-29 | 2015-12-07 | Boehringer Ingelheim Vetmedica, Inc. | Uso de una composición inmunogénica de PCV2 para reducir los síntomas clínicos en cerdos |
| CN102698263B (zh) | 2005-12-29 | 2016-07-06 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 多价pcv2免疫原性组合物和制备此类组合物的方法 |
| EP2099927A4 (en) * | 2006-11-22 | 2010-05-05 | Boehringer Ingelheim Vetmed | Methods of reducing porcine circovirus-associated disease outbreaks |
| EP2101815A4 (en) | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| RU2520087C2 (ru) * | 2006-12-15 | 2014-06-20 | Бёрингер Ингельхайм Ветмедика, Инк. | Лечение свиней с помощью антигена pcv2 |
| EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
| EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
| US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| EP2242511A4 (en) | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS |
| US20110033495A1 (en) * | 2008-02-15 | 2011-02-10 | Boehringer Ingelheim Vetmedica, Inc. | Methods and compositions for reducing the impact of enteric diseases |
| AU2008364200B2 (en) * | 2008-11-19 | 2016-01-28 | Laboratorio Avi-Mex, S.A. De C.V. | Recombinant inactivated viral vector vaccine |
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| US9932372B2 (en) | 2010-07-08 | 2018-04-03 | United Biomedical, Inc. | Designer peptide-based PCV2 vaccine |
| DK2994162T3 (en) | 2013-05-08 | 2021-06-21 | Pharmgate Biologics Inc | Vaccine for pcv2 og mycoplasma |
| US20140348874A1 (en) * | 2013-05-22 | 2014-11-27 | Boehringer Ingelheim Espana, S.A. | Method for the reduction of pcv-2 in a herd of swine |
| MX373884B (es) | 2013-10-02 | 2020-03-26 | Boehringer Ingelheim Animal Health Usa Inc | Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta. |
| BR112016012435A8 (pt) | 2013-12-03 | 2018-01-30 | Intervet Int Bv | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 |
| CA3009903C (en) * | 2015-12-28 | 2021-02-23 | Agricultural Technology Research Institute | Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same |
Family Cites Families (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| JPS60500673A (ja) | 1983-03-08 | 1985-05-09 | コモンウエルス セラム ラボラトリ−ズ コミツシヨン | 抗原活性を有するアミノ酸配列 |
| ES2052685T3 (es) * | 1987-03-17 | 1994-07-16 | Akzo Nv | Metodo para producir un adyuvante libre. |
| US5069901A (en) | 1988-02-03 | 1991-12-03 | Jones Elaine V | Preparation of a recombinant subunit vaccine against pseudorabies infection |
| DK0454735T3 (da) | 1989-01-23 | 1996-10-07 | Auspharm Int Ltd | Vaccine sammensætning |
| US5155037A (en) | 1989-08-04 | 1992-10-13 | The Texas A&M University System | Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems |
| US5202430A (en) | 1990-01-16 | 1993-04-13 | University Of Tennessee | Transmissible gastroenteritis virus genes |
| EP0597852B2 (en) | 1990-05-29 | 2005-08-10 | Wyeth Holdings Corporation | Swine pneumonia vaccine and method for the preparation thereof |
| US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| GB9023111D0 (en) | 1990-10-24 | 1990-12-05 | Wellcome Found | Expression system |
| DE69132274T2 (de) | 1990-11-01 | 2000-12-14 | Iowa State University Research Foundation, Inc. | Methode der bakteriellen attenuierung und impfstoff |
| MX9204885A (es) | 1991-08-26 | 1994-05-31 | Boehringer Animal Health Inc | Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos. |
| US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
| US5580557A (en) | 1991-10-09 | 1996-12-03 | Iowa State University Research Foundation, Inc. | Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals |
| US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| ATE365049T1 (de) | 1994-05-10 | 2007-07-15 | Wyeth Corp | Abgeänderter, verbesserter brsv lebend- impfstoff |
| US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| WO1998006855A1 (en) | 1996-08-16 | 1998-02-19 | The Texas A & M University System | Compositions and methods for delivery of nucleic acids to hepatocytes |
| DK0835930T3 (da) | 1996-10-09 | 2001-06-18 | Akzo Nobel Nv | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) |
| US7211379B2 (en) | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| US20060029617A1 (en) | 1997-10-03 | 2006-02-09 | Charreyre Catherine E | Porcine circovirus and Helicobacter combination vaccines and methods of use |
| WO1999029717A2 (en) | 1997-12-11 | 1999-06-17 | University Of Saskatchewan | Postweaning multisystemic wasting syndrome virus from pigs |
| US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| FR2781159B1 (fr) | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
| US7192594B2 (en) | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| US20040062775A1 (en) | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| AU770002B2 (en) | 1998-03-13 | 2004-02-12 | University Of Georgia Research Foundation, Inc., The | Vaccines against circovirus infections |
| US6294176B1 (en) | 1998-07-10 | 2001-09-25 | Schering-Plough Veterinary Corp. | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
| US6472193B1 (en) | 1998-11-19 | 2002-10-29 | Azwell Inc. | Recombinant lysophosphatidic acid phosphatase |
| FR2789695B1 (fr) | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
| US6497883B1 (en) | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
| US6943152B1 (en) * | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| GB9921147D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| GB9921146D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| WO2001017556A1 (fr) | 1999-09-07 | 2001-03-15 | Shionogi & Co., Ltd. | Préparations vaccinales administrables par les muqueuses |
| US6656478B1 (en) | 1999-11-12 | 2003-12-02 | Samuel D. Charles | Cross-protective salmonella vaccines |
| JP2003518073A (ja) | 1999-12-21 | 2003-06-03 | メリアル | クリプトスポリジウムパルヴァムと他の腸内病原体の抗原を含む組成物およびワクチン |
| US6808900B2 (en) | 2000-06-15 | 2004-10-26 | Manitoba, University Of | Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| JP2004503234A (ja) | 2000-06-15 | 2004-02-05 | パーデュー・リサーチ・ファウンデーション | ブタの先天性振せん用ワクチン |
| NZ524252A (en) | 2000-07-20 | 2004-03-26 | Lauras As | Cox-2 inhibitors for treating HIV and AIDS |
| MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
| US7018638B2 (en) | 2000-12-19 | 2006-03-28 | Wyeth | Mycoplasma hyopneumoniae bacterin vaccine |
| JP2002247979A (ja) | 2001-02-23 | 2002-09-03 | Nippon Biologicals Inc | マレック病ワクチンおよびその製造方法 |
| US6794163B2 (en) | 2001-03-27 | 2004-09-21 | University Of Saskatchewan | Methods to culture circovirus |
| US20030096377A1 (en) | 2001-06-28 | 2003-05-22 | Virginia Tech Intellectual Properties, Inc. | Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2 |
| DK2842569T3 (da) | 2001-07-02 | 2019-05-20 | Zoetis Services Llc | Vaccination i en dosis med Mycoplasma hyopneumoniae |
| US7361352B2 (en) | 2001-08-15 | 2008-04-22 | Acambis, Inc. | Influenza immunogen and vaccine |
| US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| US6841364B2 (en) | 2002-01-22 | 2005-01-11 | Protatek International, Inc. | Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
| AU2003219760A1 (en) | 2002-02-14 | 2003-09-04 | Novavax, Inc. | Optimization of gene sequences of virus-like particles for expression in insect cells |
| US20030199581A1 (en) | 2002-03-13 | 2003-10-23 | Seligson Allen L. | Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses |
| US20030215455A1 (en) | 2002-05-14 | 2003-11-20 | Bailey Reynolds | Vaccine stabilizer and method of use |
| US7335362B2 (en) | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
| US7223207B1 (en) | 2002-09-13 | 2007-05-29 | Simon Basyuk | Exercise and massage device |
| AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
| US7408636B2 (en) | 2002-10-31 | 2008-08-05 | Chemimage Corporation | Method and apparatus for dark field chemical imaging |
| BRPI0407207A (pt) | 2003-02-03 | 2006-01-24 | Cerebus Biolog Inc | Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter |
| US7563449B2 (en) | 2003-04-21 | 2009-07-21 | Pfizer Inc, | Methods for reducing cattle reproductive diseases |
| CN1458167A (zh) | 2003-06-02 | 2003-11-26 | 中国农业科学院哈尔滨兽医研究所 | 截短表达的猪圆环病毒ⅱ型衣壳蛋白抗原及其应用 |
| US7335361B2 (en) | 2003-06-09 | 2008-02-26 | Animal Technology Institute Taiwan | Fusion antigen used as vaccine |
| EP1651265B1 (en) | 2003-07-24 | 2008-04-23 | Merial Limited | Vaccine formulations comprising an oil-in-water emulsion |
| AU2004260657B2 (en) | 2003-07-25 | 2012-06-07 | Boehringer Ingelheim Animal Health USA Inc. | Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof |
| FR2861731B1 (fr) | 2003-10-30 | 2006-02-24 | Centre Nat Rech Scient | Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations |
| WO2005112995A1 (en) | 2004-04-26 | 2005-12-01 | Choongang Vaccine Laboratory Co., Ltd. | Inactivated mixed vaccine for porcine respiratory disease and the method of manufacturing thereof |
| CN1579553A (zh) | 2004-05-18 | 2005-02-16 | 浙江大学 | Ii型猪圆环病毒核酸疫苗的制备方法及其应用 |
| KR100478845B1 (ko) | 2004-06-22 | 2005-03-24 | 채찬희 | 돼지 이유자돈 전신성 소모성 증후군 예방 및 치료용 생물학적 조성물 |
| AU2005319716A1 (en) | 2004-06-30 | 2006-06-29 | Id Biomedical Corporation Of Quebec | Vaccine compositions for treating coronavirus infection |
| UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
| US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
| KR20070096019A (ko) | 2005-01-13 | 2007-10-01 | 베링거잉겔하임베트메디카게엠베하 | 향상된 ｐｒｒｓ 백신 |
| US7300785B2 (en) | 2005-02-03 | 2007-11-27 | Universiteit Ghent | Culturing circular ssDNA viruses for the production of vaccines |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| CN101194165B (zh) | 2005-04-13 | 2013-01-09 | 梅瑞尔有限公司 | 猪圆环病毒的生产方法及监控生产的测定法 |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| UA95458C2 (ru) | 2005-09-09 | 2011-08-10 | Интервет Интернешонал Б.В. | Вакцина против pcv-2 у mda-положительных поросят |
| CN102698263B (zh) | 2005-12-29 | 2016-07-06 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 多价pcv2免疫原性组合物和制备此类组合物的方法 |
| ES2553254T3 (es) | 2005-12-29 | 2015-12-07 | Boehringer Ingelheim Vetmedica, Inc. | Uso de una composición inmunogénica de PCV2 para reducir los síntomas clínicos en cerdos |
| EP2099927A4 (en) | 2006-11-22 | 2010-05-05 | Boehringer Ingelheim Vetmed | Methods of reducing porcine circovirus-associated disease outbreaks |
| EP2101815A4 (en) | 2006-12-11 | 2010-10-06 | Boehringer Ingelheim Vetmed | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| RU2520087C2 (ru) | 2006-12-15 | 2014-06-20 | Бёрингер Ингельхайм Ветмедика, Инк. | Лечение свиней с помощью антигена pcv2 |
| EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
| EP1958644A1 (en) * | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
| GB0712160D0 (en) | 2007-06-22 | 2007-08-01 | Univ Ghent | Methods and compositions in the treatment of procine circoviral infection |
| US20090017064A1 (en) | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| EP2242511A4 (en) | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS |
| US20110033495A1 (en) | 2008-02-15 | 2011-02-10 | Boehringer Ingelheim Vetmedica, Inc. | Methods and compositions for reducing the impact of enteric diseases |
| US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
| US20100150959A1 (en) | 2008-12-15 | 2010-06-17 | Vectogen Pty Ltd. | PCV 2-Based Methods and Compositions for the Treatment of Pigs |
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| WO2011075379A1 (en) | 2009-12-18 | 2011-06-23 | Boehringer Ingelheim Vetmedica, Inc. | Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine |
| ES2773722T3 (es) | 2010-03-16 | 2020-07-14 | Virginia Tech Intellectual Properties Inc | Vacuna de circovirus porcino quimérico atenuado vivo |
| US9580474B2 (en) | 2010-09-08 | 2017-02-28 | The Johns Hopkins University | Polyionic papilloma virus-like particle (VLP) vaccines |
| CN103122352B (zh) | 2012-09-27 | 2015-02-11 | 华中农业大学 | 一种猪圆环病毒2型重组杆状病毒及制备方法和应用 |
| EP3587439A3 (en) | 2013-03-01 | 2020-03-11 | Boehringer Ingelheim Animal Health USA Inc. | Improved quantification of vaccine compositions |
| EP2991676A1 (en) | 2013-04-30 | 2016-03-09 | Boehringer Ingelheim Vetmedica, Inc. | Orf2 protein of pcv2 subtype a (pcv2a) for use in cross-protection |
| US20140348874A1 (en) | 2013-05-22 | 2014-11-27 | Boehringer Ingelheim Espana, S.A. | Method for the reduction of pcv-2 in a herd of swine |
| WO2015026912A1 (en) | 2013-08-23 | 2015-02-26 | Boehringer Ingelheim Vetmedica, Inc. | Porcine circovirus type 2 (pcv2) subunit vaccine |
| MX373884B (es) | 2013-10-02 | 2020-03-26 | Boehringer Ingelheim Animal Health Usa Inc | Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta. |
| US10555994B2 (en) | 2015-03-30 | 2020-02-11 | Boehringer Ingelheim Animal Health USA Inc. | PCV2 ORF2 carrier platform |
-
2007
- 2007-02-13 EP EP20070102250 patent/EP1958644A1/en not_active Withdrawn
-
2008
- 2008-02-11 RU RU2009134222/15A patent/RU2520759C2/ru active
- 2008-02-11 WO PCT/EP2008/051628 patent/WO2008098909A1/en not_active Ceased
- 2008-02-11 CN CN2008800049307A patent/CN101610786B/zh active Active
- 2008-02-11 PT PT87088779T patent/PT2114447E/pt unknown
- 2008-02-11 CA CA2676568A patent/CA2676568C/en active Active
- 2008-02-11 DK DK12165993.2T patent/DK2481421T3/en active
- 2008-02-11 KR KR1020097018931A patent/KR101521465B1/ko active Active
- 2008-02-11 JP JP2009549822A patent/JP5562041B2/ja active Active
- 2008-02-11 AU AU2008214639A patent/AU2008214639B2/en active Active
- 2008-02-11 ES ES08708877T patent/ES2434117T3/es active Active
- 2008-02-11 SI SI200831057T patent/SI2114447T1/sl unknown
- 2008-02-11 EP EP12165993.2A patent/EP2481421B1/en active Active
- 2008-02-11 ES ES12165993.2T patent/ES2555132T3/es active Active
- 2008-02-11 EP EP08708877.9A patent/EP2114447B1/en active Active
- 2008-02-11 MX MX2009008577A patent/MX2009008577A/es active IP Right Grant
- 2008-02-11 PL PL08708877T patent/PL2114447T3/pl unknown
- 2008-02-11 BR BRPI0807493-3A patent/BRPI0807493A2/pt not_active Application Discontinuation
- 2008-02-11 DK DK08708877.9T patent/DK2114447T3/da active
- 2008-02-11 MY MYPI20093335 patent/MY152149A/en unknown
- 2008-02-12 CL CL200800445A patent/CL2008000445A1/es unknown
- 2008-02-12 TW TW097104856A patent/TWI438003B/zh active
- 2008-02-12 AR ARP080100605A patent/AR065319A1/es unknown
- 2008-02-13 US US12/030,611 patent/US7943298B2/en active Active
- 2008-11-02 UA UAA200909228A patent/UA100507C2/ru unknown
-
2009
- 2009-07-08 ZA ZA2009/04806A patent/ZA200904806B/en unknown
-
2011
- 2011-04-04 US US13/079,498 patent/US8496940B2/en active Active
-
2013
- 2013-06-24 US US13/924,811 patent/US9132187B2/en active Active
- 2013-11-06 CY CY20131100982T patent/CY1114577T1/el unknown
-
2015
- 2015-08-06 US US14/820,540 patent/US9555092B2/en active Active
-
2016
- 2016-12-13 US US15/377,469 patent/US9943587B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114577T1 (el) | Αποτροπη και θεραπεια υπο-κλινικης pcvd | |
| CY1121971T1 (el) | Παγιδες gdf για χρηση στη θεραπευτικη αντιμετωπιση της αναιμιας | |
| EA201001865A1 (ru) | Противовоспалительные агенты | |
| CY1113599T1 (el) | Μειωση συνακολουθων μολυνσεων σε χοιρους με τη χρηση του pcv2 αντιγονου | |
| LTPA2017009I1 (lt) | Brutono tirozinkinazės inhibitoriai | |
| AR109605A2 (es) | Método para tratar enfermedades vasculares periféricas, composición y utilización | |
| EA200800355A1 (ru) | Нейтрализующие антитела человека против b7rp1 | |
| UA100502C2 (ru) | Лечение prdc с применением антигена pcv2 | |
| DE602007013618D1 (de) | Antikörper gegen das humane cytomegalie-virus (hcmv) | |
| UA103298C2 (ru) | Способ лечения молодых свиней с помощью антигена pcv2 | |
| UA112434C2 (uk) | Антигензв'язувальний білок, який специфічно зв'язується з всма | |
| EA201100873A1 (ru) | Пиридилоксииндолы - ингибиторы vegf-r2 и их применение для лечения заболевания | |
| EA201100505A1 (ru) | Органические соединения для применения для лечения бактериальных инфекций | |
| EA200701511A1 (ru) | Фармацевтические композиции бендамустина, предназначенные для лиофилизации | |
| EP1844077A4 (en) | DR5 ANTIBODIES AND THEIR USE | |
| TR200906131T1 (tr) | Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e | |
| EA201000644A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
| CY1113094T1 (el) | Ανοσοσφαιρινες κατευθυνομενες εναντι nogo | |
| CY1115690T1 (el) | Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων | |
| ATE546153T1 (de) | Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen | |
| CY1116216T1 (el) | Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου | |
| CL2011000877A1 (es) | Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino. | |
| EA201001749A1 (ru) | Способ лечения недифференцированного артрита | |
| EA202091690A1 (ru) | Иммуногенная композиция, содержащая стафилококковые антигены | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения |